Kalbitor Alternatives Compared
| Kalbitor Remove Kalbitor from your drug comparison | Firazyr Remove Firazyr from your drug comparison | Berinert Remove Berinert from your drug comparison |
|
|---|
| Kalbitor ecallantide Remove Kalbitor from your drug comparison | Firazyr icatibant Remove Firazyr from your drug comparison | Berinert C1 esterase inhibitor (human) Remove Berinert from your drug comparison |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Hereditary Angioedema. Kalbitor may also be used for purposes not listed in this medication guide. |
Prescribed for Hereditary Angioedema. Firazyr may also be used for purposes not listed in this medication guide. |
Prescribed for Hereditary Angioedema. Berinert may also be used for purposes not listed in this medication guide. |
||||||||||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
Ratings & Reviews |
||||||||||||||||||||||||||
Drug Class |
||||||||||||||||||||||||||
Side Effects |
||||||||||||||||||||||||||
|
See the full Kalbitor side effects document. |
Common side effects include: hematoma at injection site, injection site reaction, urticaria at injection site, bruising at injection site, burning sensation at injection site, erythema at injection site, irritation at injection site, pain at injection site, swelling at injection site. See the full Firazyr side effects document. |
Common side effects include: headache. See the full Berinert side effects document. |
||||||||||||||||||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||||||||||||||||||
View all Kalbitor prices |
View all Firazyr prices and generic prices |
View all Berinert prices |
||||||||||||||||||||||||
Generic Availability |
||||||||||||||||||||||||||
|
No |
No |
|||||||||||||||||||||||||
Dosage Form(s) Available |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names |
||||||||||||||||||||||||||
|
N/A |
N/A |
Other C1 esterase inhibitor (human) brands include: Cinryze, Haegarda | ||||||||||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||||||||||||||||||
|
2.5 hours |
1.8 hours |
152 hours |
||||||||||||||||||||||||
CSA Schedule**View glossary of terms. |
||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category |
||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
Drug Interactions |
||||||||||||||||||||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 11 drugs are known to interact with Firazyr:
|
A total of 44 drugs are known to interact with Berinert:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions |
||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||||||||||
First Approval Date |
||||||||||||||||||||||||||
|
December 01, 2009 |
N/A |
N/A |
||||||||||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information |
||||||||||||||||||||||||||
Consumer Resources |
||||||||||||||||||||||||||
Professional Resources |
||||||||||||||||||||||||||
Related Treatment Guide |
||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.